Pasar al contenido principal

Investigación y educación

Enviado por remote_content el

Implications of Antibiotic Use During the COVID-19 Pandemic: The Example of Associated Antimicrobial Resistance in Latin America. Antibiotics

Investigación y Educación

Álvarez-Moreno C, Valderrama-Beltrán S.; Rodriguez-Morales A. 20/3/2021

Antimicrobials are essential for infection management. The development of antimicrobial resistance (AMR) is a growing public health problem. Globally, by the year 2050, an estimated 10 million annual deaths will be attributable to AMR [1,2]. Multi-drug resistant microorganisms have spread throughout the world, and Latin America is no exception. The reported rates of resistance to carbapenem in 2017 on average were 90%, 50%, and 10% for Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae, respectively, which are associated with poor outcomes, while the reported prevalence of resistance in methicillin-resistant Staphylococcus aureus bacteremias was 44.7%

Read full article

Artículos que te pueden interesar

Enfermedades infecciosas

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses. Lancet.

Mayo 2, 2022

Leer más

Enfermedades infecciosas

Latin America: Situation and preparedness facing the multi-country human monkeypox outbreak. Lancet Reg Health Am.

Julio 6, 2022

Leer más

Enfermedades infecciosas

Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. N Engl J Med.

Diciembre 2, 2020

Leer más